Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.com
Google Alert - NSCLC AND EMA AND Europe
Get the latest updates from Google Alert - NSCLC AND EMA AND Europe directly as they happen.
Follow now 144 followers
Latest posts
Last updated 1 day ago
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
1 day ago
... NSCLC treatment, with results to be presented at ASCO 2025. The...
Top 20 Lung Cancer Drugs Market Analysis and Segment Forecasts to 2030
1 day ago
... EU, and select Asia-Pacific regions. Agencies like the U.S. FDA and...
European regulators to review Valneva shot; Jazz's stock dips on subpar first-quarter revenue
2 days ago
Plus, news about NewAmsterdam, C4 Therapeutics, Vivo Capital, and Arcus Biosciences: EMA...
Johnson & Johnson submits application for subcutaneous Rybrevant dosing - PharmaTimes
3 days ago
Janssen-Cilag International NV, a Johnson & Johnson company, has submitted an application...
Tiragolumab/Atezolizumab Shows No Benefit in NSCLC - Medscape
4 days ago
... lung cancer (NSCLC) failed to meet its primary endpoints. ... Two...
CHMP Recommends Approval of At-Home, Subcutaneous Trastuzumab/Pertuzumab in ... - OncLive
9 days ago
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use...
The future of NSCLC treatment: what's in store for the therapeutic space?
9 days ago
... European Medicines Agency (EMA) two years ago. MAIA Biotechnology's THIO 'uncaps...
Acalabrutinib/Venetoclax With or Without Obinutuzumab Earns Positive CHMP Opinion for ...
10 days ago
The European Medicines Agency (EMA)'s Committee for Medicinal Products ... lung cancer...
CHMP Issues Positive Recommendation for Jazz Pharmaceuticals' Ziihera
14 days ago
... cancer available to patients in the EU ... EMA's CHMP Recommends...
Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment ...
14 days ago
European Medicines Agency (EMA). · European Medicines Agency (EMA). Published April 25...
Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment ...
14 days ago
... European Medicines Agency (EMA). European Medicines Agency (EMA). Published April 25...
First HER2 Therapy for Rare Biliary Cancer Gets EU Panel Backing | JAZZ Stock News
14 days ago
Jazz Pharmaceuticals (JAZZ) has received a positive opinion from the European Medicines...